Background-Inflammatory processes play a critical role in myocarditis, dilated cardiomyopathy, and heart failure. The expression of the inflammatory chemokine osteopontin (OPN) is dramatically increased in cardiomyocytes and inflammatory cells during myocarditis and heart failure in human and animals. However, its role in the development of heart diseases is not known. Methods and Results-To understand whether OPN is involved in cardiomyopathies, we generated a transgenic mouse (MHC-OPN) that specifically overexpresses OPN in cardiomyocytes with cardiac-specific promoter-directed OPN expression. Young MHC-OPN mice were phenotypically indistinguishable from their control littermates, but most of them died prematurely with a half-life of 12 weeks of age. Electrocardiography revealed conduction defects. Echocardiography showed left ventricular dilation and systolic dysfunction. Histological analysis revealed cardiomyocyte loss, severe fibrosis, and inflammatory cell infiltration. Most of these inflammatory cells were activated T cells with Th1 polarization and cytotoxic activity. Autoantibodies against OPN, cardiac myosin, or troponin I, were not found in the serum of MHC-OPN mice.
D ilated cardiomyopathy (DCM) is a major cause of nonischemic heart failure (HF). Common causes of DCM include acute ischemia and heart rhythm-related, pericardial, valvular, peripheral vascular, congenital, and familial disorders. 1 Inflammatory nature of DCM also has long been recognized triggered by acute viral or autoimmune myocarditis. 2, 3 The current understanding of molecular pathogenesis after viral myocarditis involved a 3-stage process explaining the progression from acute injury to chronic DCM. These steps include activation of the innate immune system, installation of a chronic autoimmune process inducing myocyte destruction, and finally, DCM. 4
Clinical Perspective on p 439
Osteopontin (OPN), also called cytokine Eta-1, is a chemokine involved in tissue remodeling and immunity. 5, 6 OPN is highly expressed during chronic inflammatory and autoim-mune diseases, and it is thought to play a role in inflammation through the recruitment and retention of macrophages and T cells to inflamed sites. 7 Moreover, OPN regulates the production of inflammatory cytokines in these cells. 8 OPN is also involved in the early Th1 response as demonstrated by the severely impaired type-1 immunity in OPN-deficient mice and by interferon-␥ and CD40 ligand expression in OPNstimulated human T cells. 8, 9 OPN also enhances the survival of activated T cells, suggesting that it might promote the progression of autoimmune diseases. 10 Several studies have suggested a role for OPN in cardiovascular diseases, including atherosclerosis and valvular stenosis. 7 In the heart, OPN expression is increased during both acute and chronic diseases. 11 Indeed, after myocardial infarction, OPN expression was increased in macrophages and, during cardiac hypertrophy in both humans and rodents, cardiomyocytes seem to be the major source of OPN. 12 This expression probably plays a role in fibrillogenesis. 13, 14 OPN expression coincides also with the transition from myocardial hypertrophy to HF, and its level of expression is correlated with the severity of the HF. 11 Moreover, OPN expression was increased during viral myocarditis in mouse models. 15 Findings from several experiments have therefore converged to establish a link between cardiomyopathies, including DCM and OPN expression. 14 However, the direct role of OPN in the development of DCM has not yet been determined. Here, we hypothesized that OPN might be involved in the underlying mechanisms of these diseases.
We designed a conditional transgenic mouse model that specifically expresses OPN in the heart to investigate the role of OPN in cardiomyopathies. We evidenced that expression of OPN in cardiomyocytes induces myocarditis-promoting T-cell-mediated inflammation and fibrosis in the heart, leading finally to DCM and HF.
Materials and Methods

Generation of TRE-OPN Transgenic Mice
This mouse model was constructed as previously described. 6 The mouse OPN cDNA (bases 9 to 955, accession number BC057858) was introduced into the multiple cloning site of the tetracycline transactivator (tTA)-responsive promoter of pBI-G plasmid (Clontech, St. Germain en Laye, France). Transgenic mouse lines (TRE-OPN) were produced by microinjection of this construct. We obtained 3 independent transgenic lines. These lines were used after 7 breeding with C57Bl/6 background.
Generation of MHC-OPN Mice
TRE-OPN mice were crossbred with cardiac ␣-myosin heavy chain (MHC)-tTA mice (FVB.Cg-Tg(Myh6-tTA)6Smbf/J, Jackson Laboratory) that express the transcriptional factor tTA under an MHC promoter. Crossbreeding produced the 4 following genotypes: wild type, single transgenic TRE-OPN, MHC-tTA mice, and double transgenic MHC-OPN mice. In all experiments using MHC-OPN mice, we have verified that the behavior of wild-type, MHC-tTA, and TRE-OPN littermates are not different in their level of OPN expression their survival, or show only minor differences compared with those associated with OPN expression (supplemental Figures I through III). The term "control" refers to a pool of wild type, MHC-tTA, and TRE-OPN littermates.
Mice were maintained in a conventional animal facility, on a 12-hour light/12-hour dark cycle. Food and water were available ad libitum. All procedures were carried out in compliance with the principles and guidelines established by the French National Institute of Medical Research (INSERM) and approved by the Institutional Animal Care and Use Committee. When required, doxycycline hyclate (Dox, Sigma-Aldrich, Saint Quentin Fallavier, France) was added in the drinking water (4 mg/mL).
Mouse genotypes were determined by polymerase chain reaction (PCR) with experimental conditions and primers described in the Data Supplement.
Enterovirus Myocarditis Model
A.BY/SynJ mice were bred and kept in pathogen-free conditions at the Department of Molecular Pathology, University Hospital, Tübingen, Germany. Group B coxsackievirus infection of mice and further processing of heart and sera were performed as previously described. 15 
Assessment of the Cardiac Function In Vivo
Electrocardiography
Six-lead surface ECGs were recorded with 25-gauge subcutaneous electrodes on a computer through an analog-digital converter (IOX 1.585, EMKA Technologies, Paris, France) for monitoring and later analysis (ECG Auto 1.5.7, EMKA Technologies). ECG channels were filtered between 0.5 and 250 Hz. Mice were anesthetized with an IP injection of etomidate (30 mg/kg; Janssen-Cilag, Berchem, Belgium). Body temperature was maintained at 37°C using a servo-controlled heating pad (Harvard Apparatus). The criteria used for measuring RR, PQ, QRS, and QT intervals as well as P-wave duration can be found elsewhere. 16 The QT interval was corrected for heart rate using the formula, QTcϭQT/(RR/100) 1/2 established for mice; values of QT and RR are expressed in ms. 17
Transthoracic Echocardiography
Control (nϭ15) and MHC-OPN (nϭ5) mice were lightly anesthetized with 1.5% isoflurane. Echography was performed with a 15-MHz transducer (MI2L General Electric). The percentage of left ventricular (LV) fractional shortening (%FS) was defined as %FSϭ[(LVDdϪLVDs)/LVDd]ϫ100, where LVDd is the LV enddiastolic diameter, and LVDs is the LV end-systolic diameter.
Histology and Immunohistology
For histological analysis, tissue specimens were fixed with 3% paraformaldehyde in PBS. Sections were stained with Masson trichrome or Sirius red and observed with a white light microscope. Myocyte and fibrosis densities were quantified (Sigma Scan software) on digitized images of Sirius red-stained sections.
For immunodetection, paraffin sections (8 m thick) were incubated for 2 hours with antibodies directed against OPN (Sigma Aldrich), collagen I (Novotec, Saint Martin La Garenne, France), CD31 and CD45 (Pharmingen, San Diego, Calif), CD3 (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif), CD4, CD8, tumor necrosis factor-␣, and interleukin (IL)-17 (Biolegend, San Diego, Calif). Bound biotinconjugated secondary antibodies (Sigma Aldrich) were visualized using streptavidin peroxidase-diaminobenzidine (Vector, Peterborough, UK) or streptavidin Alexa Fluor 488/568 (Invitrogen, Paisley, UK). OPN area was measured on digitized images with Sigma Scan software.
Western Blot and ELISA
Autoantibodies against OPN, cardiac myosin, and troponin I in mouse serum were detected by Western blot using protein-blotted membrane, diluted mouse serum (1%), and biotinylated anti-mouse IgG. Cardiac myosin was prepared by high ionic solution extraction and water precipitation as previously described. 18 Antitroponin I antibody and troponin I protein were provided by Dr Olivier Cazorla (Inserm U637, Montpelliers, France) and Dr Gabriele Pfitzer (Institute of Vegetative Physiology, University of Cologne, Köln, Germany), 19 respectively. Mouse OPN and OPN ELISA kit was purchased from R&D System (Abingdon, UK).
Apoptosis Assay
TUNEL assays were performed according to the manufacturer's recommendations (Roche Diagnostic, Meylan, France) using the in situ Cell Death Detection Kit.
Real-Time Quantitative Polymerase Chain Reaction (qPCR) Gene Expression Analysis
Quantitative PCR (qPCR) was performed by the Molecular Biology Platform of Angers University (available at: http://www.pftbiotechangers.com/). OPN qPCR was performed using primers described in the Data Supplement.
Statistical Analysis
For survival study, a survival plot was used and log-rank test was performed for statistical analysis. Censored variable was survival status at the time of analysis. Statistical analysis of ECG parameters was performed using either 1-way ANOVA or 2-way ANOVA tests for repeated measures, both followed up by a Tukey test when appropriate. Other statistical analyses were performed using either ANOVA followed by a Student t test when only 2 groups have to be compared or Kruskal-Wallis 1-way ANOVA followed by Mann-Whitney U test. A P value Ͻ0.05 indicated significant difference between 2 groups. Results are expressed as mean valuesϮSEM. Data were analyzed with NCSS statistical software.
Results
Experimental Model
OPN is expressed at a very low level in the normal heart of wild-type mice. To specifically express the OPN gene in cardiomyocytes, we used double transgenic MHC-OPN mice obtained by crossing MHC-tTA mice with TRE-OPN mice that carry the mouse OPN gene under the control of the tTA-responsive promoter ( Figure 1A ). Unlike in the heart of control mice, OPN mRNA and protein were strongly expressed in the heart of MHC-OPN mice ( Figure 1B Figure I) . In blood of MHC-OPN mice, OPN concentration remained low, whereas it increased coxsackievirus infected mice undergoing myocarditis ( Figure 1E ).
In MHC-OPN mice, OPN gene expression was partially inhibited by oral administration of 2 mg/mL Dox in water and completely blocked by 4 mg/mL ( Figure 1B and 1C ).
Genotypic analysis, at weaning age, of offspring resulting from the mating of MHC-tTA mice with TRE-OPN mice showed a Mendelian inheritance pattern with a gender ratio of 1:1 indicating that OPN expression in the heart had no effect on prenatal survival (supplemental Table I ).
OPN Expression in the Heart Induces Premature Death
During the first week of life, the phenotype (weight, heart/ body weight ratio, and behavior) of MHC-OPN mice was indistinguishable from that of control mice. From then, most of the MHC-OPN mice died prematurely. Therefore, we monitored the survival rate of MHC-OPN mice and their control littermates, on a weekly basis for a period of 30 weeks ( Figure 2 ). The lifespan curve showed that a huge increase in the mortality of the MHC-OPN mice compared with control mice occurred between the 8th and 15th week after birth, with a half-life of 12 weeks, and no difference was observed between genders (supplemental Figure IIIB) . To confirm the effect of OPN expression, we treated mother mice with Dox during both pregnancy and suckling and the offspring until the end of the experiment. In these conditions, OPN was not expressed in MHC-OPN embryo, pup, and adult mice, and the lifespan of these mice was identical to that of control mice up to 30 weeks of age (supplemental Table II ).
OPN Expression in the Heart Alters ECG Parameters
A follow-up study of ECG parameters was performed in MHC-OPN and control mice from 9th to 26th week after birth. Figure 3A shows representative lead-1 ECGs. At 11 weeks, the MHC-OPN mouse exhibited a markedly prolonged PQ interval and a moderately prolonged QRS interval. Repolarization was also abnormal with disappearance of the early positive phase of the T wave commonly observed in control mice. However, the QT interval was not prolonged. At 15 weeks, this mouse that died during the week after this ECG recording, showed complete atrioventricular block, with dissociation between the sinus and idioventricular escape rhythms. The T-wave duration was markedly prolonged. Quantization of ECG intervals during the last ECG recording before death of MHC-OPN mice and control mice demonstrated significant differences of PQ, QRS, QT, and QTc but not of RR between these mice ( Figure 3B and 3C) . In contrast, MHC-OPN mice that survive exhibited ECG parameters within normal values, with a moderate prolongation of PQ and QRS intervals. None of the groups exhibited either atrial or ventricular arrhythmias ( Figure 3B and 3C) . Thus, ECG analysis demonstrated that MHC-OPN mice exhibit a cardiomyopathy that could explain their premature death.
OPN Expression in the Heart Induces DCM
We evaluated the morphological and functional cardiac parameters of MHC-OPN mice by transthoracic echocardiography. Echocardiographic parameters of 6-week-old mice were identical to that of control mice (supplemental Figure V) . However, at 11 weeks, the heart LV of MHC-OPN mice was severely dilated compared with that of control mice ( Figure  4A through 4C) . Moreover, during systole, the LV free wall of MHC-OPN mice was significantly thinner than in control hearts ( Figure 4C) , which suggests the development of a hypokinetic DCM. These structural defects led to systolic dysfunction, observed as reduced LV fractional shortening (MHC-OPN mice: 13.7Ϯ4.0%, nϭ5; control mice: 29.8Ϯ2.0%, nϭ13; PϽ0.05). In vivo imaging was confirmed by a direct observation of cardiac dilation in MHC-OPN mouse that died during anesthesia ( Figure 5A and 5D ).
OPN Expression in the Heart Induces Fibrosis and Myocyte Destruction
We then performed a histological analysis. At 6 weeks, the morphology of the hearts of MHC-OPN mice did not appear to be different from that of control mice (supplemental Figure IV) . . At 15 weeks, this transgenic mouse showed complete atrioventricular block, with complete dissociation between the sinus rhythm and the idioventricular escape rhythm (not visible in such a short recording, in which P waves follow QRS complexes). Also, note the markedly prolonged T-wave duration at this age. B, Mean duration (y axis) of ECG intervals measured during the last ECG recording (respectively at 9, 11, 11, 14, and 15 weeks) before death in MHC-OPN mice (black bars; nϭ5), in 15-week-old control mice (white bars; nϭ23), and in 15-week-old MHC-OPN mice, which survived until the end of the study (gray bars; nϭ3). *PϽ0.05; **PϽ0.01; ***PϽ0.001. C, Evolution of PQ, QRS, QT, and QTc intervals as a function of age in control mice (white circles, nϭ23), in the MHC-OPN mice that survived until the end of the study (gray circles, nϭ3), and in the MHC-OPN mice that died during the study (black circles, nϭ5 at the beginning of the study; number of mice later on is given within parentheses). Statistical analysis of ECG parameters was performed using either 1-way ANOVA or 2-way ANOVA tests for repeated measures, both followed up by a Tukey test when appropriate.
After 11 weeks, the cellular organization in MHC-OPN mouse hearts was altered when compared with control hearts with evidence of myocyte loss (Figure 5B , 5E, and 5H), fibrosis ( Figure 5C , 5F, and 5I) and interstitial cell infiltration ( Figure 5B , inset) demonstrating that the disease developed very rapidly between the 6th and 11th week after birth.
Moreover, although no difference in the number of apoptotic cells in the heart of control and 6-week-old MHC-OPN mice was observed, the number of apoptotic cells was increased at 11 weeks in the MHC-OPN mouse heart ( Figure 5G ).
OPN Expression Induced Heart Inflammation
The hearts of MHC-OPN mice were infiltrated by a large number of interstitial cells. Approximately 50% of infiltrating cells expressed the panleukocyte CD45 marker ( Figure 6A ). In MHC-OPN mice under 6-week-old, the number of CD45 ϩ infiltrated cells in the heart was very low and was not different from that observed in control mice ( Figure 6B ). In early heart lesions, focal infiltration spots were observed first in the endomyocardium and the epicardium (not shown). Ten weeks after birth, CD45 ϩ cells were widespread in all parts of the myocardium with particular spots at the base of the mitral valve pillars in areas that were also associated with myocyte destruction ( Figure 6C ). As a consequence of the myocyte destruction, a strong fibroblast infiltration occurred characterized by vimentin expression ( Figure 6A ), explaining the extensive fibrosis.
Among infiltrated leukocytes (CD45 ϩ ), only a very few, not different than in the control hearts, were neutrophil granulocytes, as characterized by myeloperoxidase activity (Figure 6D and 6J ), or B lymphocytes (CD19 ϩ ) ( Figure 6J ). More unexpectedly, macrophages (Mac-3 ϩ ) were rarely observed only in rare small foci ( Figure 6E and 6J) . Most of the leukocytes were CD3 ϩ cells, thus demonstrating T-cell infiltration ( Figure 6F and 6J) . In this population, we identified helper T cells (CD4 ϩ ) ( Figure 6G ) and cytotoxic T cells (CD8 ϩ ) ( Figure 6H ) but no IL-17 ϩ T cells (data not shown). In the hearts from control mice, only a very few T cells (CD3 ϩ , CD4 ϩ , or CD8 ϩ ) were detected regardless of age (data not shown). We also observed particularly strong CD44 expression in these inflammatory cells suggesting that they were in an activated stage ( Figure 6I ). Expression of a set of Th1, Th2, and Th17 cytokines in the heart was assessed by qPCR ( Figure 7) . The strong induction of the IL-12 p40 subunit and interferon-␥ and the absence of induction of IL-4, IL-10, IL-13, and IL-17 suggested that T cells were Th1-polarized. Moreover, the expression of perforin and granzyme confirmed the existence of a cytotoxic response as suggested by the presence of large numbers of cytotoxic CD8 ϩ T cells ( Figure 6H ). Furthermore, expression of fractalkine, a molecule able to capture cytotoxic lymphocytes from blood flow and to promote their emigration, is also strongly increased (Figure 7) . 20 These data demonstrate for the first time in vivo that OPN expressed by cardiomyocytes triggers directly or indirectly T cells' recruitment and activation and retains them in the heart.
To verify whether OPN is just a trigger, we first blocked OPN expression in cardiomyocytes by administering Dox to 5-week-old MHC-OPN mice before the onset of T-cell infiltration. The survival curve of these mice during a 30-week period after birth was comparable with that of control mice, and their hearts were morphologically and histologically identical to control hearts (supplemental Table II ).
In a second set of experiments, we blocked OPN expression in 11-week-old MHC-OPN mice when DCM was evidenced (LV diameter Ͼ0.41 mm) by echocardiography ( Figure 8A) . The survival rate of this population during the next 30 weeks was identical to that of control mice (supplemental Table II ). Moreover, in Dox treated mice, OPN expression ( Figure 8B , 8E, and 8H) and inflammation ( Figure  8C , 8F, and 8I) were strongly reduced when compared with 11-week-old MHC-OPN mice. However, fibrosis (Figure 8D , 8G, and 8J) was still significantly increased demonstrating that these mice had experienced previous heart injury. The results of these experiments suggest that transient stimulation of OPN expression is not sufficient to induce or to sustain myocarditis and that chronic OPN expression in adult animals is required to sustain the inflammatory process of myocarditis that leads to DCM.
Chronic OPN Expression in Cardiomyocytes Did Not Induce a Humoral Autoimmune Response
Experimental autoimmune myocarditis is characterized by the presence of autoantibodies directed against heart proteins including cardiac myosin and troponin I. 21, 22 Different studies have indicated that OPN promotes disease progression in autoimmune models including experimental autoimmune encephalomyelitis. 23 Thus, we investigated whether OPN expression in cardiomyocytes induced autoimmune myocarditis. In the injured hearts from MHC-OPN mice, no presence of immune complexes was revealed using anti-mouse immunoglobulin (not shown). Moreover, we demonstrated that the serum of MHC-OPN mice did not contain antibodies directed against cardiac myosin, troponin I, or OPN proteins (supple-mental Figure VI) . Altogether, these experiments suggest that OPN-mediated chronic inflammation does not induce a humoral autoimmune response.
Discussion
OPN expression has been found to be increased in the heart during cardiac diseases that lead to HF, and its circulating concentration is now under consideration for use as a biomarker for the prognosis of HF. 24 Studies with OPN Ϫ/Ϫ mice have underlined the potential role of OPN in heart disease. 13, 14 However, its role not only as a marker but as an actor triggering disease had not been fully established. To elucidate the role of heart-derived OPN, we generated MHC-OPN mice that express OPN conditionally in cardiomyocytes. In these mice, a strong increase in myocardial OPN mRNA and protein expression was observed. Nevertheless, this level remained relevant to physiopathology because it was close to that observed in the heart during coxsackievirus-induced myocarditis, one of the best-characterized myocarditis model. 15 Interestingly, MHC-OPN mice died prematurely 10 to 15 weeks after birth. Clinical and histological diagnosis revealed that from the 6th week after birth, they developed spontaneous myocarditis followed by DCM with electrocardiographic abnormalities and heart block. Heart block that is found in some idiopathic myocarditis in human 2 is not a usual feature in mouse severe myocarditis models with DCM, stressing the interest of this new mouse model.
Inflammation has been recognized as a critical pathological component of a number of cardiac diseases. DCM, one of the most common heart diseases, is mainly the consequence of chronic myocarditis. 4 In MHC-OPN mice, a chronic inflammation process characterized by CD4 ϩ and CD8 ϩ T-cell infiltration was observed. Both CD4 ϩ and CD8 ϩ T cells contribute to myocarditis: CD4 ϩ helper T cells are required to initiate the pathological process, whereas cytotoxic CD8 ϩ T cells are directly involved in cardiomyocyte damage. 3 The role of OPN in T-cell recruitment was clearly demonstrated in vitro. Indeed OPN induces T-cell chemotaxis, supports T-cell adhesion, and enhances their survival. 10, 25 In vivo, only a correlation between OPN expression with T-cell infiltration was shown. 25 Our data clearly demonstrates that in vivo, local OPN expression induces T-cell recruitment at the site of OPN expression. This OPN effect could be direct through its chemotactic activity toward T cells or indirect through its ability to induce T-cell chemotactic factors such as fractalkine because OPN concentration was not increased in sera. This OPN-mediated T-cell recruitment in the heart and Th-1 polarization characterized by high expression of IL-12 and interferon-␥ and low expression of IL-4, IL-10, IL-13, and IL17 lead to myocarditis. Moreover, OPN induces the expression of the cytotoxic proteins perforin and granzyme, which are known to be involved in T-cell-mediated cardiomyocyte destruction and consequently DCM.
Myocarditis is described as a progressive disease with 3 distinct chronologically successive stages including an initial phase of myocardial injury and innate immune response, a second phase of autoimmune response, and finally, a third phase associated with DCM. 4 OPN expression is increased in several autoimmune diseases including systemic lupus ery- thematosus, rheumatoid arthritis, and inflammatory bowel disease and appears as a critical factor in the development of experimental autoimmune encephalomyelitis. 10, 23 However, conflicting results have been published regarding the role of OPN in experimental autoimmune myocarditis. Indeed, OPN expression is dramatically increased, 26 but impairment of this expression does not protect these mice from experimental autoimmune myocarditis. 27 Our results show that chronic overexpression of OPN in the heart is not sufficient to trigger a humoral autoimmune response against this protein or against cardiac myosin or troponin I. These data strongly suggest that OPN does not trigger a humoral autoimmune disease but stimulates an immunoinflammatory cellular process. This conclusion is also supported by the different patterns of inflammatory cells found in experimental autoimmune myocarditis, in which macrophages represent the largest fraction of leukocytes, 3 and in OPN-mediated myocarditis, in which only T cells are observed.
The level of circulating OPN is recognized as a marker for the shift from myocarditis to HF in experimental models and in humans. 24 Because OPN is not increased in the sera of MHC-OPN mice, our work stressed the importance of local OPN in this disease that triggers inflammation by inducing T-cell recruitment, stimulating Th-1 differentiation and inducing production of cytotoxic compounds, the consequence of which is cardiomyocyte destruction. Moreover, the mouse rescue when recombinant OPN expression was inhibited by Dox at 6 or 11 weeks of age suggested that OPN is not only a trigger of the myocarditis but also responsible for the upholding of the chronicity of the inflammatory process. Thus, we suggest that OPN may be a key element in worsening of myocarditis and progression toward HF and that it might therefore constitute a potential therapeutic target to limit HF.
